Track topics on Twitter Track topics that are important to you
CDMO acquires Syntagon, maker of novel APIs and excipients
CDMO Ardena has added drug product capabilities with the purchase of active pharmaceutical ingredient and excipient-focused Syntagon.
Contract development and manufacturing organisation acquires a specialist contract manufacturer of novel active pharmaceutical ingredients and excipients, strengthening its API offering
Ardena, a contract development and manufacturing organisation (CDMO), has acquired Syntagon, a contract manufacturer of novel active pharmaceutical ingredients (APIs) and excipients.
We have published hundreds of Syntagon news stories on BioPortfolio along with dozens of Syntagon Clinical Trials and PubMed Articles about Syntagon for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Syntagon Companies in our database. You can also find out about relevant Syntagon Drugs and Medications on this site too.